CryoLife Inc - Discussing PROACT Xa Clinical Trial Transcript
Greetings, and welcome to the CryoLife PROACT Xa Clinical Trial Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I will now turn the conference over to our host, Pat Mackin, President and Chief Executive Officer. Thank you. You may begin.
Thank you, and good afternoon, everyone. Welcome to the CryoLife investor call to discuss our PROACT Xa clinical trial.
I'm just going to throw up our forward-looking statement briefly so you can look at that.
So during this 1-hour call, I'm going to kick it off with a few opening slides to put the trial into context for our overall business. Then I'm going to turn the call -- the majority of this call is going to be Dr. John Alexander presenting, and then we'll have time at the end for Q&A.
So just a few slides on CryoLife. So when I joined about 6 years ago, we had a couple main product lines, BioGlue and our homograft tissue valves and vascular tissue. These products
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
